CSI attended and exhibited at Outsourcing in Clinical Trials 2022 in Barcelona on 4–5 May. It was an insightful conference as always, and...

The clinical supply chain is a complex process involving not only logistics, but crucially compliance. How can this be maintained? The...

Here are three ways CSI helps you overcome challenges to ensure successful delivery of your clinical trial supplies Managing clinical...

An effective comparator sourcing strategy requires the development of a robust supply chain, forecasting operations, distribution and...

In today’s global market, clinical trials are rarely isolated to one location Most clinical trials span many countries and regions, which...

There are many drivers that affect the cost of clinical trials including the cost of supplies and equipment, increased regulations,...

Pharmaceutical companies and CROs must have robust comparator sourcing strategies in place to ensure that comparator drugs are supplied...

Distribution is a crucial part of the clinical trial supply chain Following the globalisation of clinical trials, ensuring...

Clinical trials are designed in different ways depending on primary and secondary endpoints and the product being investigated Clinical...

Globalised clinical trials face a number of challenges when it comes to sourcing, supplying packaging and labelling and distributing...

The growth in the biosimilar market since 2006 has been significant. Biosimilars have no meaningful clinical differences between the...

Innovation in oncology drug development is granting cancer patients access to life-changing therapies. The industry continues to conduct...

The development of the coronavirus vaccine has dominated the pharmaceutical industry over the past year With the Pfizer-BioNTech vaccine...

For young people, learning to manage the condition is so important. There is a wealth of information out there that can help youths...

Oncology products monopolise the list of best-selling drugs. With a huge range of indications that is only growing, therapies become more specific to tumour or cell pathologies and increasing patient numbers. Several oncology products now have ‘blockbuster’ status where sales exceed $1 billion annually. This is relevant for clinical trials as more regulators require evidence of efficacy in comparison to the standard of care, which is likely to be one of the blockbuster produc

November is Lung Cancer Awareness Month 2020 in the UK. According to the NHS, lung cancer is the most common cancer in the world, with...

The global pandemic has made its presence felt in the world of clinical trials, not least in Phase 1 oncology trials. Vanessa Dekou,...

Three vaccines currently in circulation are showing high rates of effectiveness in preventing COVID-19. Pfizer-BioNTech Moderna...

Direct to patient trials have surged in popularity in the wake of the coronavirus pandemic, offering several benefits to patients and...

Successful clinical trials need effective supply chain management procedures to make sure risks are identified and managed in a timely...